Quantifying and Communicating Uncertainty in Preclinical Human Dose-Prediction
暂无分享,去创建一个
P Gennemark | M Sundqvist | A Lundahl | MB Någård | U Bredberg | P. Gennemark | U. Bredberg | A. Lundahl | M. Sundqvist | M. Nagard | Peter Gennemark | Monika Sundqvist
[1] A. Stevens. Industrial perspective. , 2000, Ultrasound in medicine & biology.
[2] U. Fagerholm. Prediction of human pharmacokinetics—evaluation of methods for prediction of hepatic metabolic clearance , 2007, The Journal of pharmacy and pharmacology.
[3] Malcolm Rowland,et al. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach. , 2011, Journal of pharmaceutical sciences.
[4] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.
[5] G. Meno-Tetang,et al. On the prediction of the human response: a recycled mechanistic pharmacokinetic/pharmacodynamic approach. , 2005, Basic & clinical pharmacology & toxicology.
[6] Franco Lombardo,et al. Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 2: Clearance , 2013, Journal of clinical pharmacology.
[7] R C Chou,et al. Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. , 1997, Journal of pharmaceutical sciences.
[8] Malcolm Rowland,et al. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution. , 2011, Journal of pharmaceutical sciences.
[9] Franco Lombardo,et al. Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 1: Volume of Distribution at Steady State , 2013, Journal of clinical pharmacology.
[10] Michael Gertz,et al. Prediction of Human Intestinal First-Pass Metabolism of 25 CYP3A Substrates from In Vitro Clearance and Permeability Data , 2010, Drug Metabolism and Disposition.
[11] Yan Li,et al. In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs. , 2012, Chemical research in toxicology.
[12] Detlof von Winterfeldt,et al. Bridging the gap between science and decision making , 2013, Proceedings of the National Academy of Sciences.
[13] J B Houston,et al. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. , 1994, Biochemical pharmacology.
[14] T Lavé,et al. Challenges and opportunities with modelling and simulation in drug discovery and drug development , 2007, Xenobiotica; the fate of foreign compounds in biological systems.
[15] Baruch Fischhoff,et al. The sciences of science communication , 2013, Proceedings of the National Academy of Sciences.
[16] Mitchell J. Small,et al. Best Practice Approaches for Characterizing, Communicating, and Incorporating Scientific Uncertainty in Decision Making , 2009 .
[17] George Loizou,et al. Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[18] S Oie,et al. Effect of altered plasma protein binding on apparent volume of distribution. , 1979, Journal of pharmaceutical sciences.
[19] Douglas Ferguson,et al. Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes , 2012, Xenobiotica; the fate of foreign compounds in biological systems.
[20] Yifeng Lu,et al. Quantitative PK–PD Model-Based Translational Pharmacology of a Novel Kappa Opioid Receptor Antagonist Between Rats and Humans , 2011, The AAPS Journal.
[21] Harold Boxenbaum,et al. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics , 1982, Journal of Pharmacokinetics and Biopharmaceutics.
[22] S. Stegemann,et al. When poor solubility becomes an issue: from early stage to proof of concept. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[23] Hyunyoung Jeong,et al. Evaluation of Using Dog as an Animal Model to Study the Fraction of Oral Dose Absorbed of 43 Drugs in Humans , 2000, Pharmaceutical Research.
[24] M. Aitken. Species differences in pharmacodynamics: Some examples , 1983, Veterinary Research Communications.
[25] T Lavé,et al. Prediction of Hepatic Metabolic Clearance Based on Interspecies Allometric Scaling Techniques and In Vitro-In Vivo Correlations , 1999, Clinical pharmacokinetics.
[26] Malcolm Rowland,et al. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance. , 2011, Journal of pharmaceutical sciences.
[27] Michael Mayersohn,et al. A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry. , 2006, Journal of pharmaceutical sciences.
[28] White House,et al. U.S. Climate Change Science Program , 2009 .
[29] Malcolm Rowland,et al. Uncertainty Analysis in Pharmacokinetics and Pharmacodynamics: Application to Naratriptan , 2005, Pharmaceutical Research.
[30] V. Aloyo,et al. Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice , 2011, Psychopharmacology.
[31] Kiyomi Ito,et al. Prediction of Human Drug Clearance from in Vitro and Preclinical Data Using Physiologically Based and Empirical Approaches , 2004, Pharmaceutical Research.
[32] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[33] K. Hole,et al. Morphine induces aggression but not analgesia in the naked mole-rat (Heterocephalus glaber). , 1990, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.
[34] Michael Gertz,et al. Physiologically Based Pharmacokinetic Modeling of Intestinal First-Pass Metabolism of CYP3A Substrates with High Intestinal Extraction , 2011, Drug Metabolism and Disposition.
[35] B. Fischhoff,et al. The role of social and decision sciences in communicating uncertain climate risks , 2011 .
[36] D. Smith. Pharmacokinetics and pharmacodynamics in toxicology. , 1997, Xenobiotica; the fate of foreign compounds in biological systems.
[37] Radhey S. Gupta,et al. Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis) , 1986, Journal of cellular physiology.
[38] Huadong Tang,et al. A NOVEL MODEL FOR PREDICTION OF HUMAN DRUG CLEARANCE BY ALLOMETRIC SCALING , 2005, Drug Metabolism and Disposition.
[39] Keith W Ward,et al. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[40] Nicholas H. G. Holford,et al. A Size Standard for Pharmacokinetics , 1996, Clinical pharmacokinetics.
[41] Bill J Smith,et al. Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches , 2009, Journal of clinical pharmacology.
[42] J. McNeill,et al. To scale or not to scale: the principles of dose extrapolation , 2009, British journal of pharmacology.
[43] Gregory F Ball,et al. Species Differences in the Relative Densities of D1- and D2-Like Dopamine Receptor Subtypes in the Japanese Quail and Rats: An in vitro Quantitative Receptor Autoradiography Study , 2009, Brain, Behavior and Evolution.
[44] Shobha Bhattachar,et al. The road map to oral bioavailability: an industrial perspective , 2006, Expert opinion on drug metabolism & toxicology.
[45] Christian P Karger,et al. A method to visualize the uncertainty of the prediction of radiobiological models. , 2013, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[46] R. Austin,et al. A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES , 2005, Drug Metabolism and Disposition.
[47] Yuichi Sugiyama,et al. Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[48] Lawrence X. Yu,et al. Applications of Human Pharmacokinetic Prediction in First-in-Human Dose Estimation , 2012, AAPS Journal.
[49] I. Mahmood. Prediction of human drug clearance from animal data: application of the rule of exponents and 'fu Corrected Intercept Method' (FCIM). , 2006, Journal of pharmaceutical sciences.
[50] W. Hayton,et al. Allometric scaling of xenobiotic clearance: Uncertainty versus universality , 2008, AAPS PharmSci.
[51] Tufve Nyholm,et al. Evaluation of uncertainty predictions and dose output for model-based dose calculations for megavoltage photon beams. , 2006, Medical physics.
[52] Susan Joy Hassol,et al. Communicating the science of climate change , 2011 .
[53] Keith W Ward,et al. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[54] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[55] U. Fagerholm,et al. Prediction of human pharmacokinetics – evaluation of methods for prediction of volume of distribution , 2007, The Journal of pharmacy and pharmacology.
[56] R. Obach,et al. DMD054031 1975..1993 , 2013 .
[57] Mike Pearson,et al. Visualizing Uncertainty About the Future , 2022 .
[58] I. Nestorov,et al. Modelling and simulation of variability and uncertainty in toxicokinetics and pharmacokinetics. , 2001, Toxicology letters.
[59] David V. Budescu,et al. Improving Communication of Uncertainty in the Reports of the Intergovernmental Panel on Climate Change , 2009, Psychological science.
[60] Peter Gennemark,et al. Automated analysis of routinely generated preclinical pharmacokinetic and pharmacodynamic data , 2014, J. Bioinform. Comput. Biol..
[61] Y. Sugiyama,et al. Evaluation of methods for predicting drug-drug interactions by Monte Carlo simulation. , 2003, Drug metabolism and pharmacokinetics.
[62] Andrew Hughes,et al. Model-based drug discovery: implementation and impact. , 2013, Drug discovery today.
[63] Erik Sjögren,et al. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[64] DE Mager,et al. Development of Translational Pharmacokinetic–Pharmacodynamic Models , 2008, Clinical pharmacology and therapeutics.
[65] Talia Flanagan,et al. In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[66] Y. Huh,et al. Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs , 2011, Xenobiotica; the fate of foreign compounds in biological systems.
[67] Patrick Poulin,et al. Dose Selection Based on Physiologically Based Pharmacokinetic (PBPK) Approaches , 2012, The AAPS Journal.
[68] Johan Gabrielsson,et al. A modeling approach for compounds affecting body composition , 2013, Journal of Pharmacokinetics and Pharmacodynamics.
[69] Philip Campbell,et al. Understanding the receivers and the reception of science's uncertain messages , 2011, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[70] Riemannian Manifolds,et al. SOME EXAMPLES OF , 1984 .
[71] James H. Brown,et al. A General Model for the Origin of Allometric Scaling Laws in Biology , 1997, Science.